vs

Side-by-side financial comparison of CABOT CORP (CBT) and HANOVER INSURANCE GROUP, INC. (THG). Click either name above to swap in a different company.

HANOVER INSURANCE GROUP, INC. is the larger business by last-quarter revenue ($1.7B vs $849.0M, roughly 2.0× CABOT CORP). HANOVER INSURANCE GROUP, INC. runs the higher net margin — 11.9% vs 8.6%, a 3.3% gap on every dollar of revenue. On growth, HANOVER INSURANCE GROUP, INC. posted the faster year-over-year revenue change (5.5% vs -11.1%). HANOVER INSURANCE GROUP, INC. produced more free cash flow last quarter ($377.0M vs $57.0M). Over the past eight quarters, HANOVER INSURANCE GROUP, INC.'s revenue compounded faster (3.8% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

The Hanover Insurance Group, Inc. is an insurance company based in Worcester, Massachusetts. It was the original name of a property-liability insurance firm established in 1852, and it remained a publicly traded company under that name until the early 1990s, when it changed its name to Allmerica Property & Casualty Companies.

CBT vs THG — Head-to-Head

Bigger by revenue
THG
THG
2.0× larger
THG
$1.7B
$849.0M
CBT
Growing faster (revenue YoY)
THG
THG
+16.6% gap
THG
5.5%
-11.1%
CBT
Higher net margin
THG
THG
3.3% more per $
THG
11.9%
8.6%
CBT
More free cash flow
THG
THG
$320.0M more FCF
THG
$377.0M
$57.0M
CBT
Faster 2-yr revenue CAGR
THG
THG
Annualised
THG
3.8%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
THG
THG
Revenue
$849.0M
$1.7B
Net Profit
$73.0M
$198.5M
Gross Margin
24.9%
Operating Margin
15.2%
17.3%
Net Margin
8.6%
11.9%
Revenue YoY
-11.1%
5.5%
Net Profit YoY
-21.5%
18.2%
EPS (diluted)
$1.37
$5.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
THG
THG
Q4 25
$849.0M
$1.7B
Q3 25
$899.0M
$1.7B
Q2 25
$923.0M
$1.7B
Q1 25
$936.0M
$1.6B
Q4 24
$955.0M
$1.6B
Q3 24
$1.0B
$1.6B
Q2 24
$1.0B
$1.5B
Q1 24
$1.0B
$1.6B
Net Profit
CBT
CBT
THG
THG
Q4 25
$73.0M
$198.5M
Q3 25
$43.0M
$178.7M
Q2 25
$101.0M
$157.1M
Q1 25
$94.0M
$128.2M
Q4 24
$93.0M
$167.9M
Q3 24
$137.0M
$102.1M
Q2 24
$109.0M
$40.5M
Q1 24
$84.0M
$115.5M
Gross Margin
CBT
CBT
THG
THG
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
CBT
CBT
THG
THG
Q4 25
15.2%
17.3%
Q3 25
15.2%
14.9%
Q2 25
18.1%
12.7%
Q1 25
17.3%
11.6%
Q4 24
16.2%
16.1%
Q3 24
15.0%
9.6%
Q2 24
16.9%
6.2%
Q1 24
15.3%
9.7%
Net Margin
CBT
CBT
THG
THG
Q4 25
8.6%
11.9%
Q3 25
4.8%
10.7%
Q2 25
10.9%
9.5%
Q1 25
10.0%
8.0%
Q4 24
9.7%
10.6%
Q3 24
13.7%
6.5%
Q2 24
10.7%
2.6%
Q1 24
8.2%
7.4%
EPS (diluted)
CBT
CBT
THG
THG
Q4 25
$1.37
$5.46
Q3 25
$0.80
$4.90
Q2 25
$1.86
$4.30
Q1 25
$1.69
$3.50
Q4 24
$1.67
$4.60
Q3 24
$2.41
$2.80
Q2 24
$1.94
$1.12
Q1 24
$1.49
$3.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
THG
THG
Cash + ST InvestmentsLiquidity on hand
$230.0M
$1.1B
Total DebtLower is stronger
$843.3M
Stockholders' EquityBook value
$1.6B
$3.6B
Total Assets
$3.8B
$16.9B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
THG
THG
Q4 25
$230.0M
$1.1B
Q3 25
$258.0M
$915.7M
Q2 25
$239.0M
$244.1M
Q1 25
$213.0M
$315.1M
Q4 24
$183.0M
$435.5M
Q3 24
$223.0M
$427.1M
Q2 24
$197.0M
$337.6M
Q1 24
$206.0M
$264.6M
Total Debt
CBT
CBT
THG
THG
Q4 25
$843.3M
Q3 25
$1.1B
$843.0M
Q2 25
$347.8M
Q1 25
$722.5M
Q4 24
$722.3M
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
THG
THG
Q4 25
$1.6B
$3.6B
Q3 25
$1.6B
$3.4B
Q2 25
$1.5B
$3.2B
Q1 25
$1.4B
$3.0B
Q4 24
$1.4B
$2.8B
Q3 24
$1.4B
$2.9B
Q2 24
$1.3B
$2.6B
Q1 24
$1.4B
$2.5B
Total Assets
CBT
CBT
THG
THG
Q4 25
$3.8B
$16.9B
Q3 25
$3.8B
$16.8B
Q2 25
$3.8B
$15.7B
Q1 25
$3.8B
$15.5B
Q4 24
$3.6B
$15.3B
Q3 24
$3.7B
$15.4B
Q2 24
$3.6B
$14.9B
Q1 24
$3.6B
$14.6B
Debt / Equity
CBT
CBT
THG
THG
Q4 25
0.24×
Q3 25
0.70×
0.25×
Q2 25
0.11×
Q1 25
0.24×
Q4 24
0.25×
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
THG
THG
Operating Cash FlowLast quarter
$126.0M
$378.2M
Free Cash FlowOCF − Capex
$57.0M
$377.0M
FCF MarginFCF / Revenue
6.7%
22.6%
Capex IntensityCapex / Revenue
8.1%
0.1%
Cash ConversionOCF / Net Profit
1.73×
1.91×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
THG
THG
Q4 25
$126.0M
$378.2M
Q3 25
$219.0M
$554.4M
Q2 25
$249.0M
$206.6M
Q1 25
$73.0M
$38.9M
Q4 24
$124.0M
$213.5M
Q3 24
$204.0M
$394.7M
Q2 24
$207.0M
$139.5M
Q1 24
$176.0M
$58.7M
Free Cash Flow
CBT
CBT
THG
THG
Q4 25
$57.0M
$377.0M
Q3 25
$155.0M
$551.4M
Q2 25
$188.0M
$204.9M
Q1 25
$1.0M
$37.1M
Q4 24
$47.0M
$210.5M
Q3 24
$112.0M
$392.3M
Q2 24
$155.0M
$137.3M
Q1 24
$133.0M
$56.1M
FCF Margin
CBT
CBT
THG
THG
Q4 25
6.7%
22.6%
Q3 25
17.2%
33.1%
Q2 25
20.4%
12.4%
Q1 25
0.1%
2.3%
Q4 24
4.9%
13.3%
Q3 24
11.2%
25.1%
Q2 24
15.3%
8.9%
Q1 24
13.1%
3.6%
Capex Intensity
CBT
CBT
THG
THG
Q4 25
8.1%
0.1%
Q3 25
7.1%
0.2%
Q2 25
6.6%
0.1%
Q1 25
7.7%
0.1%
Q4 24
8.1%
0.2%
Q3 24
9.2%
0.2%
Q2 24
5.1%
0.1%
Q1 24
4.2%
0.2%
Cash Conversion
CBT
CBT
THG
THG
Q4 25
1.73×
1.91×
Q3 25
5.09×
3.10×
Q2 25
2.47×
1.32×
Q1 25
0.78×
0.30×
Q4 24
1.33×
1.27×
Q3 24
1.49×
3.87×
Q2 24
1.90×
3.44×
Q1 24
2.10×
0.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

THG
THG

Personal Lines Segment$684.6M41%
Core Commercial Lines Segment$617.8M37%
Specialty Lines Segment$377.9M23%

Related Comparisons